Walleye Capital LLC Sells 29,486 Shares of Ultralife Co. (NASDAQ:ULBI)

Walleye Capital LLC trimmed its position in Ultralife Co. (NASDAQ:ULBI) by 53.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,466 shares of the technology company’s stock after selling 29,486 shares during the quarter. Walleye Capital LLC owned 0.15% of Ultralife worth $230,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Rhumbline Advisers boosted its position in Ultralife by 1,728.3% during the second quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock worth $125,000 after acquiring an additional 11,165 shares during the last quarter. Juncture Wealth Strategies LLC purchased a new stake in shares of Ultralife in the 3rd quarter valued at approximately $165,000. XTX Topco Ltd increased its position in shares of Ultralife by 192.1% in the 2nd quarter. XTX Topco Ltd now owns 37,399 shares of the technology company’s stock valued at $397,000 after purchasing an additional 24,595 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Ultralife by 203.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 39,111 shares of the technology company’s stock valued at $415,000 after buying an additional 26,206 shares in the last quarter. Finally, ClariVest Asset Management LLC boosted its holdings in shares of Ultralife by 2.9% in the 2nd quarter. ClariVest Asset Management LLC now owns 66,657 shares of the technology company’s stock valued at $708,000 after buying an additional 1,864 shares in the last quarter. Institutional investors own 30.68% of the company’s stock.

Ultralife Stock Performance

ULBI stock opened at $7.75 on Wednesday. The company has a market capitalization of $128.86 million, a P/E ratio of 14.09 and a beta of 0.95. The company has a 50-day simple moving average of $8.39 and a 200 day simple moving average of $9.70. Ultralife Co. has a fifty-two week low of $6.36 and a fifty-two week high of $13.39. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04.

Wall Street Analyst Weigh In

ULBI has been the subject of a number of recent research reports. StockNews.com cut shares of Ultralife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, October 3rd. Benchmark restated a “buy” rating and set a $14.00 target price on shares of Ultralife in a report on Friday, November 15th.

Ultralife Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.